Alterations in Sphingolipid Composition and Mitochondrial Complex I Deficiency Represent Synergistic Therapeutic Vulnerabilities Linked to Vincristine Resistance

Kelsey H. Fisher‐Wellman(Atrium Health Wake Forest Baptist), Myles C. Cabot(University of Virginia Cancer Center)

Research Square

May 12, 2021

10.21203/rs.3.rs-506642/v1

Cited by 0

Related Papers

Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells

|Journal of Lipid Research|2019|40

Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia

|Cancers|2023|6

Acute myeloid leukemia mitochondria hydrolyze ATP to resist chemotherapy

|bioRxiv (Cold Spring Harbor Laboratory)|2024|2

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia

|Research Square|2021|1

Impact of physiological media on acute myeloid leukemia bioenergetics and cell proliferation

|Cancer & Metabolism|2025|1